GMC 6139

Drug Profile

GMC 6139

Latest Information Update: 18 Jan 2001

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Goteborg University; Lundbeck A/S; Merck AG; University of Groningen
  • Class Antipsychotics; Dibenzazepines; Small molecules
  • Mechanism of Action Dopamine D1 receptor antagonists; Dopamine D2 receptor antagonists; Serotonin 2A receptor antagonists; Serotonin 2C receptor antagonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Schizophrenia

Most Recent Events

  • 18 Jan 2001 Discontinued-Preclinical for Schizophrenia in Netherlands (Unknown route)
  • 15 Dec 1999 New profile
  • 14 Dec 1999 Preclinical development for Schizophrenia in Netherlands (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top